Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system
Barbara Toffoli, Federica Gilardi, Carine Winkler, et al.
PLoS ONE (2017) Vol. 12, Iss. 2, pp. e0171474-e0171474
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Anthos Christofides, Eirini Konstantinidou, Chinmay Jani, et al.
Metabolism (2020) Vol. 114, pp. 154338-154338
Open Access | Times Cited: 439
Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan, Ben Tang, Chun Zhang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 213
PPAR-Mediated Toxicology and Applied Pharmacology
Yue Xi, Yunhui Zhang, Sirui Zhu, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 352-352
Open Access | Times Cited: 84
PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys
Gábor Kökény, Laurent Calvier, Georg Hansmann
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10431-10431
Open Access | Times Cited: 72
The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
Jianjun Gao, Zhaoyan Gu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 43
Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome
Richa Pant, Priyanka Firmal, Vibhuti Kumar Shah, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 45
The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review
Yanhao Qiu, Mailin Gan, Xingyu Wang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127042-127042
Closed Access | Times Cited: 17
Non-genetic mechanisms of diabetic nephropathy
Qiuxia Han, Hanyu Zhu, Xiangmei Chen, et al.
Frontiers of Medicine (2017) Vol. 11, Iss. 3, pp. 319-332
Closed Access | Times Cited: 59
Nuclear receptors in podocyte biology and glomerular disease
Shipra Agrawal, John Cijiang He, Pierre‐Louis Tharaux
Nature Reviews Nephrology (2020) Vol. 17, Iss. 3, pp. 185-204
Closed Access | Times Cited: 46
Nuclear receptors in the kidney during health and disease
Andrew E. Libby, Bryce A. Jones, Isabel Lopez-Santiago, et al.
Molecular Aspects of Medicine (2020) Vol. 78, pp. 100935-100935
Open Access | Times Cited: 35
Exploring the Mechanism of Yougui Pill against Aging Based on Network Pharmacology and Molecular Docking Study
Haiyan Yang, Qian Shi, C.-Y. Ji
Chinese medicine and natural products (2025) Vol. 05, Iss. 01, pp. e47-e58
Open Access
Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases
Alpana Singh, Rishabh Chaudhary
International Immunopharmacology (2025) Vol. 155, pp. 114616-114616
Closed Access
Lack of Adipocytes Alters Hematopoiesis in Lipodystrophic Mice
Anne Wilson, He Fu, M. J. Schiffrin, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 32
Systemic PPARγ deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility
Federica Gilardi, Carine Winkler, Laure Quignodon, et al.
Metabolism (2019) Vol. 95, pp. 8-20
Open Access | Times Cited: 31
PPARγ and Its Agonists in Chronic Kidney Disease
Yuhua Ma, Manman Shi, Yuxin Wang, et al.
International Journal of Nephrology (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 28
Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy
Y Chen, Meiqi Lu, Mengshu Lin, et al.
Lupus (2024) Vol. 33, Iss. 4, pp. 347-356
Closed Access | Times Cited: 3
PPARG: A Novel Target for Yellow Tea in Kidney Stone Prevention
Mingjie Su, Siyao Sang, Taotao Liang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11955-11955
Open Access | Times Cited: 7
Roles of pyroptosis and immune infiltration in aortic dissection
Xiaogang Ge, Qiqi Cai, Yangyang Cai, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Prediction of Drug Positioning for Quan-Du-Zhong Capsules Against Hypertensive Nephropathy Based on the Robustness of Disease Network
Feifei Guo, Wen Zhang, Jin Su, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 20
PPARs/macrophages: A bridge between the inflammatory response and lipid metabolism in autoimmune diseases
Zikang Wang, Miao Wang, Xiaoyu Xu, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 684, pp. 149128-149128
Closed Access | Times Cited: 6
Hemicentin 1 influences podocyte dynamic changes in glomerular diseases
Barbara Toffoli, Cristina Zennaro, Carine Winkler, et al.
AJP Renal Physiology (2018) Vol. 314, Iss. 6, pp. F1154-F1165
Open Access | Times Cited: 17
The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes
Almudena García-Carrasco, Adriana Izquierdo‐Lahuerta, Ángela M. Valverde, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1868, Iss. 7, pp. 159329-159329
Open Access | Times Cited: 4
Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic Mice
Maria‐Bernadette Madel, He Fu, Dominique D. Pierroz, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 10
Exploring the role of Xingren on COVID ‐19 based on network pharmacology and molecular docking
Maoru Wang, Bin Yu, Jisheng Wang, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 10
Open Access | Times Cited: 7
Genetics and Clinical Characteristics of PPARγ Variant-Induced Diabetes in a Chinese Han Population
Siqian Gong, Xueyao Han, Meng Li, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top